US drug advisory recommends Celltrion’s Rituxan biosimilar for approval
기사승인 2018.10.11 12:10:11
Lee Han-soo corea022@docdocdoc.co.kr
- 1PharmaPharmaceuticals seek fresh start with new CEOs
- 2PolicyGyeonggi Province’s effort to eradicate ‘ghost surgery’ stirs up controversy
- 3Device/ICTMedtronic’s subcontractor worker aided surgery at NMC
- 4Hospital‘Smart hospitals’ to reduce repetitive nursing work
- 5PolicyThis year’s MERS crisis should be springboard for future
- 6PharmaSanofi-Aventis Korea unveils sub-analysis for dyslipidemia therapy
- 7People‘Nursing students drew lots to choose enema training subject’
set_C1
